Artelo Biosciences, Inc. ( ARTL) - Stock Earnings
ARTL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
ARTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.2 million USD | — USD |
| 2026Q1 | -3.0 million USD | — USD |
| 2026Q2 | -2.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ARTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.3 million USD | — USD |
| 2024 | -9.8 million USD | — USD |
| 2025 | -12.9 million USD | — USD |
| 2026 Est. | — | — |
ARTL
Price: $0.73
52 week price:
Earnings Per Share: -11.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36149
Market Capitalization: 3.4 million